Eliav Barr
- Hepatology top 0.5%
- Hepatitis C virus research 24
- Epidemiology top 0.1%
- Hepatitis B Virus Studies 35
- Cervical Cancer and HPV Research 33
- Liver Disease Diagnosis and Treatment 11
- Microbiology top 0.5%
- Health top 0.5%
- Surgery top 0.5%
- Genital Health and Disease 16
-
- HIV/AIDS drug development and treatment 13
-
- Immunotherapy and Immune Responses 9
-
- Antiplatelet Therapy and Cardiovascular Diseases 4
- Co-authors
- Cosette M. WheelerLaura A. KoutskyKathrin U. JansenKevin A. AultDarron R. BrownFrances B. AlvarezJeffrey M. LeidenJanine T. Bryan
- Cited by
- HepatologyEpidemiologyMicrobiology
- Partner nations
- United StatesFranceCanada
In The Last Decade
Eliav Barr
75 papers receiving 9.9k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Hepatology 1.9k
- Epidemiology 7.6k
- Microbiology 680
- Health 739
- Surgery 2.9k
Countries citing papers authored by Eliav Barr
This map shows the geographic impact of Eliav Barr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliav Barr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliav Barr more than expected).
Fields of papers citing papers by Eliav Barr
This network shows the impact of papers produced by Eliav Barr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliav Barr. The network helps show where Eliav Barr may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eliav Barr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 9 | |
| 2 | 2019 | 5 | |
| 3 | 2018 | 9 | |
| 4 | 2018 | 2 | |
| 5 | 2017 | 58 | |
| 6 | 2015 | 77 | |
| 7 | Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 studybreakdown → | 2015 | 477 |
| 8 | 2015 | 218 | |
| 9 | 2015 | 109 | |
| 10 | Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Malesbreakdown → | 2011 | 821 |
| 11 | 2008 | 4 | |
| 12 | 2008 | 25 | |
| 13 | 2007 | 225 | |
| 14 | 2006 | 21 | |
| 15 | 2006 | 338 | |
| 16 | 2001 | 19 | |
| 17 | 2001 | 63 | |
| 18 | 1999 | 27 | |
| 19 | 1996 | 72 | |
| 20 | 1992 | 99 |
About Eliav Barr
Eliav Barr is a scholar working on Hepatology, Epidemiology and Transplantation, having authored 75 papers that have together received 10.4k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (35 papers), Cervical Cancer and HPV Research (33 papers), Hepatitis C virus research (24 papers), Genital Health and Disease (16 papers), HIV/AIDS drug development and treatment (13 papers), Liver Disease Diagnosis and Treatment (11 papers), Immunotherapy and Immune Responses (9 papers) and Antiplatelet Therapy and Cardiovascular Diseases (4 papers). The work is most often cited by research in Hepatology (1.9k citations), Epidemiology (7.6k citations) and Microbiology (680 citations). Eliav Barr has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Cosette M. Wheeler, Laura A. Koutsky, Kathrin U. Jansen, Kevin A. Ault, Darron R. Brown, Frances B. Alvarez, Jeffrey M. Leiden, Janine T. Bryan, Heather L. Sings and Mark T. Esser. Their work appears in journals such as Vaccine, Gastroenterology, The Journal of Infectious Diseases, Hepatology and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.